Fresenius SE & Co. KGaA Stock Forecast, Price & News

-0.15 (-1.24 %)
(As of 09/17/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume28,338 shs
Average Volume24,524 shs
Market Capitalization$26.59 billion
P/E Ratio12.85
Dividend Yield1.49%
30 days | 90 days | 365 days | Advanced Chart
Receive FSNUY News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius SE & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

Fresenius SE & Co. KGaA logo

About Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed, and Corporate and Other. The Fresenius Medical Care segment comprises of dialysis products and healthcare services. The Fresenius Kabi segment specializes in intravenous drugs, clinical nutrition, infusion therapy, medical devices, and transfusion technology. The Fresenius Helios focuses on the private hospital operations. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The Corporate and Other segment includes the holding activities. The company was founded by Eduard Fresenius in October 1912 and is headquartered in Bad Homburg, Germany.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value





Social Links


Overall MarketRank

2.62 out of 5 stars

Analyst Opinion: 3.3Community Rank: 4.1Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 3.1 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Frequently Asked Questions

Is Fresenius SE & Co. KGaA a buy right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Fresenius SE & Co. KGaA in the last year. There are currently 4 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Fresenius SE & Co. KGaA stock.
View analyst ratings for Fresenius SE & Co. KGaA
or view top-rated stocks.

What stocks does MarketBeat like better than Fresenius SE & Co. KGaA?

Wall Street analysts have given Fresenius SE & Co. KGaA a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Fresenius SE & Co. KGaA wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Fresenius SE & Co. KGaA?

Fresenius SE & Co. KGaA saw a increase in short interest in the month of August. As of August 13th, there was short interest totaling 36,400 shares, an increase of 145.9% from the July 29th total of 14,800 shares. Based on an average daily volume of 36,800 shares, the days-to-cover ratio is currently 1.0 days.
View Fresenius SE & Co. KGaA's Short Interest

When is Fresenius SE & Co. KGaA's next earnings date?

Fresenius SE & Co. KGaA is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Fresenius SE & Co. KGaA

How were Fresenius SE & Co. KGaA's earnings last quarter?

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) issued its earnings results on Friday, July, 30th. The company reported $0.26 earnings per share for the quarter. The business earned $11.14 billion during the quarter. Fresenius SE & Co. KGaA had a trailing twelve-month return on equity of 6.98% and a net margin of 4.78%.
View Fresenius SE & Co. KGaA's earnings history

How has Fresenius SE & Co. KGaA's stock price been impacted by COVID-19 (Coronavirus)?

Fresenius SE & Co. KGaA's stock was trading at $10.13 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, FSNUY stock has increased by 18.0% and is now trading at $11.95.
View which stocks have been most impacted by COVID-19

How often does Fresenius SE & Co. KGaA pay dividends? What is the dividend yield for Fresenius SE & Co. KGaA?

Fresenius SE & Co. KGaA announced a dividend on Wednesday, May 19th. Shareholders of record on Tuesday, May 25th will be paid a dividend of $0.5164 per share on Thursday, June 3rd. This represents a yield of 3.76%. The ex-dividend date of this dividend is Monday, May 24th.
View Fresenius SE & Co. KGaA's dividend history

Is Fresenius SE & Co. KGaA a good dividend stock?

Fresenius SE & Co. KGaA pays an annual dividend of $0.18 per share and currently has a dividend yield of 1.49%. The dividend payout ratio of Fresenius SE & Co. KGaA is 19.57%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Fresenius SE & Co. KGaA will have a dividend payout ratio of 16.82% next year. This indicates that Fresenius SE & Co. KGaA will be able to sustain or increase its dividend.
View Fresenius SE & Co. KGaA's dividend history.

What price target have analysts set for FSNUY?

11 Wall Street analysts have issued 1 year price objectives for Fresenius SE & Co. KGaA's shares. Their forecasts range from $13.36 to $13.36. On average, they anticipate Fresenius SE & Co. KGaA's stock price to reach $13.36 in the next year. This suggests a possible upside of 11.8% from the stock's current price.
View analysts' price targets for Fresenius SE & Co. KGaA
or view top-rated stocks among Wall Street analysts.

Who are Fresenius SE & Co. KGaA's key executives?

Fresenius SE & Co. KGaA's management team includes the following people:
  • Stephan Sturm, President & Chief Executive Officer
  • Rachel Clare Empey, Chief Financial Officer
  • Sebastian Biedenkopf, Legal, Compliance & Human Resources Director
  • Rice Powell, Chief Executive Officer-Fresenius Medical Care
  • Francesco De Meo, Chief Executive Officer-Fresenius Helios

Who are some of Fresenius SE & Co. KGaA's key competitors?

What is Fresenius SE & Co. KGaA's stock symbol?

Fresenius SE & Co. KGaA trades on the OTCMKTS under the ticker symbol "FSNUY."

How do I buy shares of Fresenius SE & Co. KGaA?

Shares of FSNUY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Fresenius SE & Co. KGaA's stock price today?

One share of FSNUY stock can currently be purchased for approximately $11.95.

How much money does Fresenius SE & Co. KGaA make?

Fresenius SE & Co. KGaA has a market capitalization of $26.59 billion and generates $41.44 billion in revenue each year. The company earns $1.95 billion in net income (profit) each year or $0.92 on an earnings per share basis.

How many employees does Fresenius SE & Co. KGaA have?

Fresenius SE & Co. KGaA employs 311,269 workers across the globe.

When was Fresenius SE & Co. KGaA founded?

Fresenius SE & Co. KGaA was founded in 1912.

What is Fresenius SE & Co. KGaA's official website?

The official website for Fresenius SE & Co. KGaA is www.fresenius.com.

Where are Fresenius SE & Co. KGaA's headquarters?

Fresenius SE & Co. KGaA is headquartered at Else-Kroner-Strasse 1, Bad Homburg 2M, 61352.

How can I contact Fresenius SE & Co. KGaA?

Fresenius SE & Co. KGaA's mailing address is Else-Kroner-Strasse 1, Bad Homburg 2M, 61352. The company can be reached via phone at (496) 172-6080 or via email at [email protected]

This page was last updated on 9/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.